CDG Therapeutics, Inc. is a Chicago-based, clinical stage biotechnology company engaged in the development and commercialization of proprietary, cell penetrating peptides (CPPs) that cross the blood brain barrier, preferentially enter cancer cells, induce cancer cell cycle arrest and ultimately cell death.

from http://www.cdgti.com/about/

Research Grants 1 show all


$186.9K
2011

Patents 39show all

  • 34
    A61K - Preparations for medical, dental, or toilet purposes
  • 31
    C07K - Peptides
  • 22
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 17
    Y02A - Technologies for adaptation to climate change
  • 8
    C12N - Microorganisms or enzymes

Clinical Trials 1show all

1Phase 1

SEC Filings show all


1
D

Contact Information

Elk Grove Village, IL
United States

SEC Form D Funding Events

DateOfferedSoldType
2008-02-20Unknown Unknown Other (Paper Filing)